Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease.
Identifieur interne : 000029 ( Ncbi/Merge ); précédent : 000028; suivant : 000030Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease.
Auteurs : Anne-Marie Canakis [Canada] ; Ernest Cutz ; David Manson ; Hugh O'BrodovichSource :
- American journal of respiratory and critical care medicine [ 1073-449X ] ; 2002.
Descripteurs français
- KwdFr :
- Association thérapeutique, Femelle, Glycogénose (), Glycogénose (diagnostic), Glycogénose (mortalité), Hormones corticosurrénaliennes (administration et posologie), Humains, Immunohistochimie, Indice de gravité médicale, Mâle, Nouveau-né, Pneumopathies interstitielles (), Pneumopathies interstitielles (anatomopathologie), Pneumopathies interstitielles (imagerie diagnostique), Pneumopathies interstitielles (mortalité), Ponction-biopsie à l'aiguille, Taux de survie, Tomodensitométrie, Ventilation artificielle, Études de suivi.
- MESH :
- administration et posologie : Hormones corticosurrénaliennes.
- anatomopathologie : Pneumopathies interstitielles.
- diagnostic : Glycogénose.
- imagerie diagnostique : Pneumopathies interstitielles.
- mortalité : Glycogénose, Pneumopathies interstitielles.
- Association thérapeutique, Femelle, Glycogénose, Humains, Immunohistochimie, Indice de gravité médicale, Mâle, Nouveau-né, Pneumopathies interstitielles, Ponction-biopsie à l'aiguille, Taux de survie, Tomodensitométrie, Ventilation artificielle, Études de suivi.
English descriptors
- KwdEn :
- Adrenal Cortex Hormones (administration & dosage), Biopsy, Needle, Combined Modality Therapy, Female, Follow-Up Studies, Glycogen Storage Disease (diagnosis), Glycogen Storage Disease (mortality), Glycogen Storage Disease (therapy), Humans, Immunohistochemistry, Infant, Newborn, Lung Diseases, Interstitial (congenital), Lung Diseases, Interstitial (diagnostic imaging), Lung Diseases, Interstitial (mortality), Lung Diseases, Interstitial (pathology), Male, Respiration, Artificial, Severity of Illness Index, Survival Rate, Tomography, X-Ray Computed.
- MESH :
- chemical , administration & dosage : Adrenal Cortex Hormones.
- congenital : Lung Diseases, Interstitial.
- diagnosis : Glycogen Storage Disease.
- diagnostic imaging : Lung Diseases, Interstitial.
- mortality : Glycogen Storage Disease, Lung Diseases, Interstitial.
- pathology : Lung Diseases, Interstitial.
- therapy : Glycogen Storage Disease.
- Biopsy, Needle, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Immunohistochemistry, Infant, Newborn, Male, Respiration, Artificial, Severity of Illness Index, Survival Rate, Tomography, X-Ray Computed.
Abstract
We present the clinical, radiologic, and pathologic findings in lung biopsies from seven infants with atypical neonatal lung disease. All seven infants presented with tachypnea, hypoxemia, and diffuse interstitial infiltrates with overinflated lungs on chest radiographs in the first month of life. Lung biopsies from all cases showed similar pathology, with expansion of the interstitium by spindle-shaped cells containing periodic acid-Schiff positive diastase labile material consistent with glycogen. Immunohistochemical staining showed these cells to be vimentin positive but negative for leucocyte common antigen, lysozyme, and other macrophage markers. Electron microscopy revealed primitive interstitial mesenchymal cells with few cytoplasmic organelles and abundant monoparticulate glycogen. Minimal or no glycogen was seen in the alveolar lining cells. Five cases were treated with pulse corticosteroids; hydroxychloroquine was added in one case. Six of seven infants have shown a favorable clinical outcome. One infant died from complications of extreme prematurity and bronchopulmonary dysplasia. Three cases that have been followed for at least 6 years have shown clinical resolution and radiographic improvement. We propose the term "pulmonary interstitial glycogenosis" of the neonate for this new entity to be differentiated from other forms of interstitial lung disease. Because abundant glycogen is not normally found in pulmonary interstitial cells, we postulate an abnormality in lung cytodifferentiation involving interstitial mesenchymal cells.
DOI: 10.1164/rccm.2105139
PubMed: 12045133
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000469
- to stream PubMed, to step Curation: 000469
- to stream PubMed, to step Checkpoint: 000443
Links to Exploration step
pubmed:12045133Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease.</title><author><name sortKey="Canakis, Anne Marie" sort="Canakis, Anne Marie" uniqKey="Canakis A" first="Anne-Marie" last="Canakis">Anne-Marie Canakis</name><affiliation wicri:level="4"><nlm:affiliation>Division of Respiratory Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Respiratory Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Cutz, Ernest" sort="Cutz, Ernest" uniqKey="Cutz E" first="Ernest" last="Cutz">Ernest Cutz</name></author><author><name sortKey="Manson, David" sort="Manson, David" uniqKey="Manson D" first="David" last="Manson">David Manson</name></author><author><name sortKey="O Brodovich, Hugh" sort="O Brodovich, Hugh" uniqKey="O Brodovich H" first="Hugh" last="O'Brodovich">Hugh O'Brodovich</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12045133</idno><idno type="pmid">12045133</idno><idno type="doi">10.1164/rccm.2105139</idno><idno type="wicri:Area/PubMed/Corpus">000469</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000469</idno><idno type="wicri:Area/PubMed/Curation">000469</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000469</idno><idno type="wicri:Area/PubMed/Checkpoint">000443</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000443</idno><idno type="wicri:Area/Ncbi/Merge">000029</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease.</title><author><name sortKey="Canakis, Anne Marie" sort="Canakis, Anne Marie" uniqKey="Canakis A" first="Anne-Marie" last="Canakis">Anne-Marie Canakis</name><affiliation wicri:level="4"><nlm:affiliation>Division of Respiratory Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Respiratory Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario</wicri:regionArea><orgName type="university">Université de Toronto</orgName><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Cutz, Ernest" sort="Cutz, Ernest" uniqKey="Cutz E" first="Ernest" last="Cutz">Ernest Cutz</name></author><author><name sortKey="Manson, David" sort="Manson, David" uniqKey="Manson D" first="David" last="Manson">David Manson</name></author><author><name sortKey="O Brodovich, Hugh" sort="O Brodovich, Hugh" uniqKey="O Brodovich H" first="Hugh" last="O'Brodovich">Hugh O'Brodovich</name></author></analytic><series><title level="j">American journal of respiratory and critical care medicine</title><idno type="ISSN">1073-449X</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenal Cortex Hormones (administration & dosage)</term><term>Biopsy, Needle</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Glycogen Storage Disease (diagnosis)</term><term>Glycogen Storage Disease (mortality)</term><term>Glycogen Storage Disease (therapy)</term><term>Humans</term><term>Immunohistochemistry</term><term>Infant, Newborn</term><term>Lung Diseases, Interstitial (congenital)</term><term>Lung Diseases, Interstitial (diagnostic imaging)</term><term>Lung Diseases, Interstitial (mortality)</term><term>Lung Diseases, Interstitial (pathology)</term><term>Male</term><term>Respiration, Artificial</term><term>Severity of Illness Index</term><term>Survival Rate</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term><term>Femelle</term><term>Glycogénose ()</term><term>Glycogénose (diagnostic)</term><term>Glycogénose (mortalité)</term><term>Hormones corticosurrénaliennes (administration et posologie)</term><term>Humains</term><term>Immunohistochimie</term><term>Indice de gravité médicale</term><term>Mâle</term><term>Nouveau-né</term><term>Pneumopathies interstitielles ()</term><term>Pneumopathies interstitielles (anatomopathologie)</term><term>Pneumopathies interstitielles (imagerie diagnostique)</term><term>Pneumopathies interstitielles (mortalité)</term><term>Ponction-biopsie à l'aiguille</term><term>Taux de survie</term><term>Tomodensitométrie</term><term>Ventilation artificielle</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adrenal Cortex Hormones</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Hormones corticosurrénaliennes</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Pneumopathies interstitielles</term></keywords><keywords scheme="MESH" qualifier="congenital" xml:lang="en"><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Glycogen Storage Disease</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Glycogénose</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Pneumopathies interstitielles</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Glycogen Storage Disease</term><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Glycogénose</term><term>Pneumopathies interstitielles</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung Diseases, Interstitial</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Glycogen Storage Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Biopsy, Needle</term><term>Combined Modality Therapy</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Immunohistochemistry</term><term>Infant, Newborn</term><term>Male</term><term>Respiration, Artificial</term><term>Severity of Illness Index</term><term>Survival Rate</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term><term>Femelle</term><term>Glycogénose</term><term>Humains</term><term>Immunohistochimie</term><term>Indice de gravité médicale</term><term>Mâle</term><term>Nouveau-né</term><term>Pneumopathies interstitielles</term><term>Ponction-biopsie à l'aiguille</term><term>Taux de survie</term><term>Tomodensitométrie</term><term>Ventilation artificielle</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We present the clinical, radiologic, and pathologic findings in lung biopsies from seven infants with atypical neonatal lung disease. All seven infants presented with tachypnea, hypoxemia, and diffuse interstitial infiltrates with overinflated lungs on chest radiographs in the first month of life. Lung biopsies from all cases showed similar pathology, with expansion of the interstitium by spindle-shaped cells containing periodic acid-Schiff positive diastase labile material consistent with glycogen. Immunohistochemical staining showed these cells to be vimentin positive but negative for leucocyte common antigen, lysozyme, and other macrophage markers. Electron microscopy revealed primitive interstitial mesenchymal cells with few cytoplasmic organelles and abundant monoparticulate glycogen. Minimal or no glycogen was seen in the alveolar lining cells. Five cases were treated with pulse corticosteroids; hydroxychloroquine was added in one case. Six of seven infants have shown a favorable clinical outcome. One infant died from complications of extreme prematurity and bronchopulmonary dysplasia. Three cases that have been followed for at least 6 years have shown clinical resolution and radiographic improvement. We propose the term "pulmonary interstitial glycogenosis" of the neonate for this new entity to be differentiated from other forms of interstitial lung disease. Because abundant glycogen is not normally found in pulmonary interstitial cells, we postulate an abnormality in lung cytodifferentiation involving interstitial mesenchymal cells.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12045133</PMID><DateCompleted><Year>2002</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1073-449X</ISSN><JournalIssue CitedMedium="Print"><Volume>165</Volume><Issue>11</Issue><PubDate><Year>2002</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am. J. Respir. Crit. Care Med.</ISOAbbreviation></Journal><ArticleTitle>Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease.</ArticleTitle><Pagination><MedlinePgn>1557-65</MedlinePgn></Pagination><Abstract><AbstractText>We present the clinical, radiologic, and pathologic findings in lung biopsies from seven infants with atypical neonatal lung disease. All seven infants presented with tachypnea, hypoxemia, and diffuse interstitial infiltrates with overinflated lungs on chest radiographs in the first month of life. Lung biopsies from all cases showed similar pathology, with expansion of the interstitium by spindle-shaped cells containing periodic acid-Schiff positive diastase labile material consistent with glycogen. Immunohistochemical staining showed these cells to be vimentin positive but negative for leucocyte common antigen, lysozyme, and other macrophage markers. Electron microscopy revealed primitive interstitial mesenchymal cells with few cytoplasmic organelles and abundant monoparticulate glycogen. Minimal or no glycogen was seen in the alveolar lining cells. Five cases were treated with pulse corticosteroids; hydroxychloroquine was added in one case. Six of seven infants have shown a favorable clinical outcome. One infant died from complications of extreme prematurity and bronchopulmonary dysplasia. Three cases that have been followed for at least 6 years have shown clinical resolution and radiographic improvement. We propose the term "pulmonary interstitial glycogenosis" of the neonate for this new entity to be differentiated from other forms of interstitial lung disease. Because abundant glycogen is not normally found in pulmonary interstitial cells, we postulate an abnormality in lung cytodifferentiation involving interstitial mesenchymal cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Canakis</LastName><ForeName>Anne-Marie</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cutz</LastName><ForeName>Ernest</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Manson</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>O'Brodovich</LastName><ForeName>Hugh</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2002 Jun 1;165(11):1466-7</RefSource><PMID Version="1">12045116</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2016 Mar 15;193(6):694-6</RefSource><PMID Version="1">26977970</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001707" MajorTopicYN="N">Biopsy, Needle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006008" MajorTopicYN="N">Glycogen Storage Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017563" MajorTopicYN="N">Lung Diseases, Interstitial</DescriptorName><QualifierName UI="Q000151" MajorTopicYN="N">congenital</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>6</Month><Day>5</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>7</Month><Day>4</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>6</Month><Day>5</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12045133</ArticleId><ArticleId IdType="doi">10.1164/rccm.2105139</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><noCountry><name sortKey="Cutz, Ernest" sort="Cutz, Ernest" uniqKey="Cutz E" first="Ernest" last="Cutz">Ernest Cutz</name><name sortKey="Manson, David" sort="Manson, David" uniqKey="Manson D" first="David" last="Manson">David Manson</name><name sortKey="O Brodovich, Hugh" sort="O Brodovich, Hugh" uniqKey="O Brodovich H" first="Hugh" last="O'Brodovich">Hugh O'Brodovich</name></noCountry><country name="Canada"><region name="Ontario"><name sortKey="Canakis, Anne Marie" sort="Canakis, Anne Marie" uniqKey="Canakis A" first="Anne-Marie" last="Canakis">Anne-Marie Canakis</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000029 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000029 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:12045133
|texte= Pulmonary interstitial glycogenosis: a new variant of neonatal interstitial lung disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:12045133" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |